Skip to content

Lifestyle5 min read

AI Smart T-Shirt Detects Inherited Heart Disorders in UK

An innovative AI-powered smart T-shirt from Imperial College London aims to revolutionize detection of inherited heart rhythm disorders, preventing sudden cardiac deaths in thousands.

Share

Topics

Your next heart test may start with a T‑shirt: Imperial College creates AI smart T-shirt to spot hidden inherited heart rhythm risks

Imperial College London researchers have built an AI‑powered smart T‑shirt with up to 50 woven ECG sensors for comfortable, continuous monitoring — designed to unmask inherited rhythm disorders such as Brugada syndrome that short ECGs can miss.

Key takeaways

  • Innovation: An AI smart T‑shirt with up to 50 woven ECG‑style sensors records long, real‑world heart data — Imperial College news release.
  • AI training: Algorithm trained on ECGs from more than 1,000 people to distinguish subtle, intermittent signs of inherited rhythm disorders.
  • Trials: A feasibility study will ask ~200 volunteers to wear the shirt for up to three months to test detection, comfort and wearability.
  • Support: Funded with >£340,000 from the British Heart Foundation and backed by NIHR Imperial Biomedical Research Centre.

Overview

Who: Researchers at Imperial College London, led by Professor Zachary Whinnett, have developed an AI‑assisted smart T‑shirt to improve detection of inherited heart rhythm disorders.

How the AI smart T‑shirt heart monitoring works

Traditional tests offer snapshots: hospital ECGs last minutes and many home monitors record only 24–48 hours using sticky electrodes and an external monitor. Those brief recordings can miss intermittent, dangerous signals.

The smart T‑shirt embeds up to 50 ECG‑style sensors into soft sportswear fabric so users can wear it under clothing, sleep and wash the garment. The shirt captures continuous electrical signals during daily life; an AI algorithm then searches that extended record for subtle patterns linked to inherited rhythm disorders.

Design priorities include comfort and day‑to‑day wearability so people keep wearing the device and clinicians receive real‑world, long‑duration data rather than a brief snapshot.

Why extended monitoring matters

Inherited rhythm disorders can be silent for years and may produce abnormal ECG patterns only intermittently. A short test taken during a calm moment can appear normal and miss dangerous signs. Continuous monitoring creates context — repeated small signals that look like noise on one test can show a clear pattern over days or weeks.

The Imperial team says continuous records could unmask conditions such as Brugada syndrome that are frequently hidden by short tests. See reporting on real‑world implications in Medical Xpress.

AI development and training

Data: The AI was trained on ECGs from more than 1,000 people, including individuals with inherited rhythm disorders and controls. This mixed dataset helps the model learn to separate normal variation from true risk signals.

“Far too many people die from inherited heart conditions which could be treated if they were identified earlier… We hope our AI‑assisted T‑shirt will provide a practical and comfortable solution.” — Professor Zachary Whinnett

Planned trials and next steps

The next step is a feasibility study at Hammersmith Hospital’s Peart‑Rose Research Unit. About 200 patients and volunteers will wear the shirt continuously for up to three months. Researchers will evaluate detection accuracy, comfort, wearability and AI performance on long, real‑world recordings.

If results are promising, the team plans larger trials and regulatory review. Investigators estimate potential clinical availability in roughly five years, subject to trial outcomes and approvals; initial work focuses on adults with possible adaptation for children and other conditions (for example, atrial fibrillation) if safe and effective.

Funding and expert support

The project has received more than £340,000 in funding from the British Heart Foundation and is supported by the NIHR Imperial Biomedical Research Centre. British Heart Foundation Professor James Leiper said the work will harness AI to help clinicians unmask hidden conditions and identify patients at risk of sudden death.

Safety, privacy and practical questions

Innovation raises practical issues that must be addressed:

  • Data privacy: Continuous heart recordings are medical data. Secure storage, clear access rules and compliance with medical device and health‑record standards are essential — see the team’s discussion at Imperial College.
  • Accuracy and false alarms: Screening must balance sensitivity against false positives; too many false alarms cause anxiety and unnecessary testing. The planned trials will quantify true‑positive and false‑positive rates.
  • Access and cost: Widespread benefit depends on affordability, reimbursement and health‑system planning for who pays for devices and analysis.
  • Regulation: Devices combining hardware and AI will need regulatory review (for example, FDA pathways in the U.S.) to ensure safety and effectiveness.

Why conservatives might back this approach

The smart T‑shirt resonates with conservative priorities: it empowers patients with at‑home testing, may reduce long‑term costs by preventing emergencies, supports academic and market innovation, and calls for sensible regulation and strong data protections. Policymakers can champion patient choice and clear standards to ensure trustworthy deployment.

Additional context: the human toll researchers hope to cut

Inherited rhythm disorders can strike without warning and sometimes affect young people. Imperial researchers note the scale of the problem in the U.K.; extended monitoring seeks earlier diagnosis, timely treatment and prevention of sudden deaths that currently have no warning signs.

Implications for the United States

Economic and health‑system impact: If reliable, the T‑shirt could shift some cardiac screening from clinics to homes, reducing emergency visits and expensive interventions by catching problems early. Coverage decisions by private insurers and public payers (Medicare, Medicaid) would shape access, especially in rural areas.

Regulatory and clinical adoption: U.S. regulators would require robust trials; the combined device‑plus‑AI will likely be reviewed as a medical device and software medical device. Clear, science‑based approval pathways can protect patients while enabling innovation.

Privacy and data ownership: Americans value health privacy. Policymakers and companies must define data ownership, retention and access rules so insurers and employers cannot misuse continuous heart data.

Research and collaboration: U.S. institutions and companies may partner on trials or develop competing products; early international collaboration among regulators, clinicians and developers could accelerate safe adoption.

Sources and further reading

Note: All facts, figures and source URLs in this report are preserved from the original materials cited above.

Share

Topics

Kevin Morgan

Kevin Morgan is a senior food and dining writer for Times Media Service, based in Los Angeles, California. Morgan covers food and dining, along with sports and health, bringing an evidence-based, community-focused approach to health reporting. Morgan holds a master's degree in sport administration and grew up in Canton, Ohio.

Write to Kevin